Bolsonaro Questions Laboratories and Says that They Should Be Interested in Selling their Vaccines to Brazil

According to the Anvisa website, there has been no authorization request made


A Target of criticism because of Brazil's delay in the vaccination against Covid-19, President Jair Bolsonaro (no party) questioned, on Monday (28), the laboratories responsible for developing immunizers and said that they should be interested in selling their products to the country.

FILE PHOTO - BRASILIA, DF, BRASIL, 16-12-2020: President Jair Bolsonaro. (Foto: Pedro Ladeira/Folhapress, PODER) - Folhapress

"Brazil has 210 million inhabitants, which means a huge consumer market for just about anything. Shouldn't the laboratories be interested in selling to us? Why don't they present the documentation [for certification] to Anvisa [National Health Surveillance Agency] ? ", asked the president during a conversation with supporters at Palácio da Alvorada, in Brasília.

"People say I have to go after it. No, if I am the one selling it, I want to make the presentation," he added.

According to the Anvisa website, there has been no request for emergency authorization or registration made by any company.

Bolsonaro government's forecast is to receive at least 150 million doses of different vaccines in the first semester of next year. This total includes immunizers from Sinovac / Butantan, AstraZeneca / University of Oxford, and Pfizer / BioNTech.

Translated by Cassy Dias

Read the article in the original language